Rosuvastatin Calcium Tablet
Product Images NDC 68071-3668

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68071-3668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3668 9)

Pdp (68071 3668 9)
Rosuvastatin Calcium 5 mg tablet label from NuCare Pharmaceuticals, Inc. The label states a package size of 90 tablets. It includes manufacturer details from United Laboratories Pvt. Ltd., India, and packaging by NuCare Pharmaceuticals, Inc. Usage instructions and warnings such as "Keep out of reach of children" and storage temperature are also printed. NDC number 68071-3668 is visible.*
FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
A Kaplan-Meier curve showing cumulative incidence (%) over 5 years for two groups: Placebo (dotted line) and Rosuvastatin Calcium (solid line). The graph includes a hazard ratio (HR 0.56, 95% CI 0.46-0.69) and P value (<0.001). Below the graph, numbers at risk at various time points are listed for RSV (Rosuvastatin) and Placebo groups.*
FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
A data table presenting the number of events for various cardiovascular endpoints comparing Rosuvastatin 20 mg and placebo, including primary end point, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization. The table shows event rates per 1000 patient years, hazard ratios with 95% confidence intervals, P values, and a corresponding hazard ratio plot.*
FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
A box plot chart comparing percent change from baseline in LDL-C levels for different doses of four statins: Rosuvastatin Calcium (Crestor), Atorvastatin, Simvastatin, and Pravastatin. The x-axis lists doses in mg for each drug, and the y-axis shows percent change from 0 to -75. The chart visually compares LDL-C reduction effectiveness among these statins at various doses.*
FDA Label Image
FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Structural_formula (Rosuvastatin Tablets Structure)
Chemical structure diagram of Rosuvastatin Calcium showing the molecular arrangement including fluorophenyl and sulfonyl methyl groups, along with calcium ions (Ca2+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.